Jakafi improved control of chronic graft-versus-host disease, according to recent research. Among patients with chronic graft-versus-host disease (cGVHD) ...

One of my favorite country songs is by North Carolina recording artist and American Idol winner, Scotty McCreery. The title of the song is "Five More ...

It is important that patients with cancer do not lose hope, regardless of what their clinicians say, explained one survivor.Doctors don’t know everything.“I ...

Minimal residual disease may offer treatment insights for patients with AML.After patients with acute monocytic leukemia (AML) undergo induction ...

The International Agency for Research on Cancer (IARC) has finalised its evaluation of possible links between two ‘forever chemicals’ and cancer in ...

Autologous hematopoietic cell transplantation (auto-HCT) resulted in lower relapse rates and improved rates of survival without disease progression compared ...

Enlarged spleen is a common symptom of myelofibrosis, but a new regimen of navitoclax and Jakafi may help, recent findings showed.The combination of ...

Orca-T, a type of blood cancer therapy that is made of donor stem and immune cells, led to promising rates of relapse-free survival (RFS; time after ...

Yescarta boosted survival in patients with pretreated large B-cell lymphoma, research showed. Yescarta (axicabtagene ciloleucel) showed an improvement in ...

An artificial intelligence (AI) platform that analyzed bone marrow biopsies and digital disease images was able to differentiate cases of prefibrotic ...